Cargando…
Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526028/ https://www.ncbi.nlm.nih.gov/pubmed/34657562 http://dx.doi.org/10.1080/0886022X.2021.1988967 |
| _version_ | 1784585792795967488 |
|---|---|
| author | Wang, Di Wang, Yan Sun, Shiren |
| author_facet | Wang, Di Wang, Yan Sun, Shiren |
| author_sort | Wang, Di |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8526028 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85260282021-10-20 Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone Wang, Di Wang, Yan Sun, Shiren Ren Fail Letter to the Editor Taylor & Francis 2021-10-17 /pmc/articles/PMC8526028/ /pubmed/34657562 http://dx.doi.org/10.1080/0886022X.2021.1988967 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Wang, Di Wang, Yan Sun, Shiren Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone |
| title | Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone |
| title_full | Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone |
| title_fullStr | Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone |
| title_full_unstemmed | Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone |
| title_short | Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone |
| title_sort | renal pathological changes after successful treatment of lcdd using cyclophosphamide, thalidomide, and dexamethasone |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526028/ https://www.ncbi.nlm.nih.gov/pubmed/34657562 http://dx.doi.org/10.1080/0886022X.2021.1988967 |
| work_keys_str_mv | AT wangdi renalpathologicalchangesaftersuccessfultreatmentoflcddusingcyclophosphamidethalidomideanddexamethasone AT wangyan renalpathologicalchangesaftersuccessfultreatmentoflcddusingcyclophosphamidethalidomideanddexamethasone AT sunshiren renalpathologicalchangesaftersuccessfultreatmentoflcddusingcyclophosphamidethalidomideanddexamethasone |